Physician
Neurology
Dr. Kirk A. Frey, MD
|
|
Give Review
Kirk A. Frey, MD practices Neurology. He studied medicine at University of Michigan Medical School. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Kirk Frey is also a published MD. He has 75 paper published. The most recent paper is: Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease. Doctor Kirk A. Frey, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease.
- ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia.
- Post-Mortem evaluation of amyloid-dopamine terminal positron emission tomography Dementia classifications.
- Autoimmune Limbic Encephalitis Detected on FDG Brain Scan Performed for the Evaluation of Dementia.
- Imaging Amyloidopathy in Parkinson Disease and Parkinsonian Dementia Syndromes.
- Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction Effects.
- Clinical markers for identifying cholinergic deficits in Parkinson's Disease.
- Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson Disease.
- Extra-nigral pathological conditions are common in Parkinson's Disease with freezing of gait: An in vivo positron emission tomography study.
- High Affinity Radiopharmaceuticals Based Upon Lansoprazole for PET Imaging of Aggregated Tau in Alzheimer's Disease and Progressive Supranuclear Palsy: Synthesis, Prec...
- Changes in functional lung regions during the course of radiation therapy and their potential impact on lung dosimetry for non-small cell lung cancer.
- Advanced Age, Cardiovascular Risk Burden, and Timed Up and Go Test Performance in Parkinson Disease.
- In Vivo Imaging of Human Cholinergic Nerve Terminals with (-)-5-18F-Fluoroethoxybenzovesamicol: Biodistribution, Dosimetry, and Tracer Kinetic Analyses.
- Modifiable cardiovascular risk factors and axial motor impairments in Parkinson Disease.
- Gender differences in cholinergic and dopaminergic deficits in Parkinson Disease.
- Thalamic cholinergic innervation and postural sensory integration function in Parkinson's Disease.
- Gait speed in Parkinson Disease correlates with cholinergic degeneration.
- Predictive Models for Regional Hepatic Function Based on 99mTc-IDA SPECT and Local Radiation Dose for Physiologic Adaptive Radiation Therapy.
- Diabetes is associated with postural instability and gait difficulty in Parkinson Disease.
- Assessing Mild Cognitive Impairment with Amyloid and Dopamine Terminal Molecular Imaging.
- Preablation 131-I Scans With SPECT/CT in Postoperative Thyroid Cancer Patients: What Is the Impact on Staging?
- β-amyloid and postural instability and gait difficulty in Parkinson's Disease at risk for dementia.
- Imaging of acute pulmonary embolism.
- Aβ-amyloid deposition in patients with Parkinson Disease at risk for development of dementia.
- Heterogeneity of cholinergic denervation in Parkinson's Disease without dementia.
- Pattern of Cardiac Sympathetic Denervation in Idiopathic Parkinson Disease Studied with 11C Hydroxyephedrine PET.
- WE-A-217A-04: Hepatic Function Estimated from HIDA SPECT for Assessment of Liver Response to Radiation Therapy.
- Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson Disease.
- Changes in Global Function and Regional Ventilation and Perfusion on SPECT During the Course of Radiotherapy in Patients with Non-Small-Cell Lung Cancer.
- Postmenopausal hormone use impact on emotion processing circuitry.
- Early Initiation of Hormone Therapy in Menopausal Women Is Associated with Increased Hippocampal and Posterior Cingulate Cholinergic Activity.
- Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's Disease.
- ABNM Position Statement: Nuclear Medicine Professional Competency and Scope of Practice.
- Cerebral glucose metabolic features of Parkinson Disease and incident dementia: longitudinal study.
- Semiquantification and classification of local pulmonary function by V/Q single photon emission computed tomography in patients with non-small cell lung cancer: potent...
- Comparison of single time-point [111-In] pentetreotide SPECT/CT with dual time-point imaging of neuroendocrine tumors.
- Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT.
- Early menopausal hormone use influences brain regions used for visual working memory.
- False positive diagnosis of metastatic esophageal carcinoma on positron emission tomography: a case report of cholecystitis simulating a hepatic lesion.
- Comparing fludeoxyglucose F18-PET assessment of regional Cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cogniti...
- Incremental value of 111-in pentetreotide SPECT/CT fusion imaging of neuroendocrine tumors.
- FDG PET imaging of childhood sarcomas.
- Utility of delayed whole-body bone scintigraphy after directed three-phase scintigraphy.
- Advanced squamous cell carcinoma of the oropharynx: efficacy of positron emission tomography and computed tomography for determining primary tumor response during indu...
- Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma.
- Vertebral body hemangioma visualized on Tc-99m HMPAO-labeled leukocyte SPECT/CT.
- Spared caudal brainstem SERT binding in early Parkinson's Disease.
- Differentiating Alzheimer's Disease from dementia with Lewy bodies and Parkinson's Disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
- A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer.
- Reduced gamma-aminobutyric acid(A)-benzodiazepine binding sites in insular cortex of individuals with panic disorder.
- Imaging of cholinergic and monoaminergic neurochemical changes in neurodegenerative disorders.
- Imaging butyrylcholinesterase activity in Alzheimer's Disease.
- Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson Disease.
- Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.
- In vivo butyrylcholinesterase activity is not increased in Alzheimer's Disease synapses.
- Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy.
- Dopaminergic abNormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin.
- Hippocampal inactivation disrupts the acquisition and contextual encoding of fear extinction.
- 11C-DTBZ and 18F-FDG PET measures in differentiating Dementias.
- Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain.
- Neurochemical imaging of Dementias.
- The role of positron emission tomography imaging in movement disorders.
- Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole.
- Diminished striatal [123I]iodobenzovesamicol binding in idiopathic cervical Dystonia.
- Initial agonist treatment of Parkinson Disease: a critique.
- Striatal monoaminergic terminals in Lewy body and Alzheimer's Dementias.
- Cholinergic vesicular transporters in progressive supranuclear Palsy.
- Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice.
- Brain PET in Suspected Dementia: Patterns of Altered FDG Metabolism.
- Invited commentary on "structural and functional imaging in parkinsonian syndromes".
- Insomnia and sleepiness in Parkinson Disease: associations with symptoms and comorbidities.
- Single-photon emission computed tomography/computed tomography as a problem-solving tool in patients with suspected acute cholecystitis.
- Inter-method Comparison and Optimization of [18F] FDG PET Metabolic Response Assessment in Non-Small Cell Lung Cancer.
- Hepatic Function Model Based Upon HIDA SPECT and Dose for Physiological Adaptive RT.
Schools
University of Mi Med Sch
St Joseph Mercy Hospital
University Mich Hosps
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Bell's Palsy
- Cerebral Artery Thrombosis
- View All
Doctors Specialties
- Neurology
- Nuclear Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Michigan Hospitals and Health Centers -
St Joseph Mercy Livingston Hospital -
University of Michigan Medical School
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1841382892 | |
| NPPES Provider LastName | FREY | |
| NPPES Provider FirstName | KIRK | |
| NPPES Provider ZIPCode | 481095028 | |
| NPPES Provider State | MI | |
| Specialty Description | Nuclear Medicine | |
| Total Claim Count | 25.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1841382892 |
| Last Name Of The Provider | FREY |
| First Name Of The Provider | KIRK |
| View All |
Similar Doctors
|
|
Dr. William T. Dauer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Soe M. Aung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sid Gilman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harry S. Greenberg, MD |
|
|
Dr. Brian E. Woodruff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Simon M. Glynn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David H. Woodbury Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Markus Schwaiger, MD |
|
|
Dr. Ronald D. Chervin, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Anita V. Shelgikar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Molly G. Rossknecht, DO |
|
|
Dr. Sung M. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Lorraine M. Fig, MB CHB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kurt M. Sieloff, MD |
|
|
Dr. Jessica L. Stulc, MD |